A Robust Portfolio of Prototype Assays
The power of Elecsys® in Alzheimer's disease
Robust and accurate biomarker tests to solve clinical questions
- Elecsys® assays achieve highly accurate and precise results across all Cobas® platforms, with the precision being confirmed in the Alzheimer's Association Quality Control (AAQC) program;
- Elecsys® assays show robust reagent and calibration stability.
AAQC results (2014-2020)
The green box and whiskers plots are manual assay results, and the blue ones are automated assay results.
This box and whisker plot shows the coefficient of variation (in %) from the AAQC rounds (years 2014-2020). The variability is far lower with automated platforms (depicted in blue) than manual platforms (depicted in green).
COBAS, COBAS E and ELECSYS are trademarks of Roche